2D- and 3D-cultures of human trabecular meshwork cells: A preliminary assessment of an in vitro model for glaucoma study.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 22 05 2019
accepted: 19 08 2019
entrez: 7 9 2019
pubmed: 7 9 2019
medline: 7 3 2020
Statut: epublish

Résumé

A physiologically relevant in vitro human-based model could be the 'gold standard' to clarify the pathological steps involved in glaucoma onset. In this regard, human 3D cultures may represent an excellent starting point to achieve this goal. Indeed, the 3D matrix allows to re-create the in vivo-like tissue architecture, maintaining its functionality and cellular behaviour, compared to the 2D model. Thus, we propose a comparison between the 2D and 3D in vitro models of human trabecular meshwork cells in terms of cellular responses after chronic stress exposure. Our results showed that 3D-cells are more sensitive to intracellular reactive oxidative specie production induced by hydrogen peroxide treatment, compared to 2D cultures. Additionally, in 3D cultures a more accurate regulation of the apoptosis trigger and cell adaptation mechanisms was detected than in 2D models. In line with these findings, the 3D-HTMC model shows the ability to better mimic the in vivo cell behaviour in adaptive responses to chronic oxidative stress than 2D.

Identifiants

pubmed: 31490976
doi: 10.1371/journal.pone.0221942
pii: PONE-D-19-13032
pmc: PMC6731014
doi:

Substances chimiques

Cytokines 0
NF-kappa B 0
Reactive Oxygen Species 0
Hydrogen Peroxide BBX060AN9V

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0221942

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Cell Biol. 1999 May 17;145(4):757-67
pubmed: 10330404
Free Radic Biol Med. 1999 Sep;27(5-6):612-6
pubmed: 10490282
Hum Genet. 2000 Nov;107(5):494-8
pubmed: 11140948
Nat Med. 2001 Mar;7(3):304-9
pubmed: 11231628
Genome Biol. 2002 Jun 18;3(7):RESEARCH0034
pubmed: 12184808
Biochim Biophys Acta. 2006 Aug;1758(8):994-1003
pubmed: 16566894
Nature. 2006 May 25;441(7092):431-6
pubmed: 16724054
Curr Cancer Drug Targets. 2009 Jun;9(4):451-68
pubmed: 19519315
Free Radic Biol Med. 2010 Apr 15;48(8):1064-70
pubmed: 20100568
Arch Ophthalmol. 2011 Jan;129(1):48-55
pubmed: 21220628
Am J Pathol. 2011 Jan;178(1):26-31
pubmed: 21224039
Biol Reprod. 2011 Aug;85(2):417-24
pubmed: 21566000
PLoS One. 2012;7(2):e31340
pubmed: 22319624
J Biomed Biotechnol. 2012;2012:692609
pubmed: 22665989
Cell Biochem Funct. 2014 Apr;32(3):217-28
pubmed: 23963693
J Cell Mol Med. 2013 Dec;17(12):1619-31
pubmed: 24118792
PLoS One. 2013 Oct 04;8(10):e76373
pubmed: 24124550
Cell Mol Life Sci. 2014 Jun;71(12):2197-218
pubmed: 24142347
J Anat. 2015 Dec;227(6):746-56
pubmed: 25411113
Oncol Rep. 2015 Apr;33(4):1837-43
pubmed: 25634491
Cell Biochem Biophys. 2015 Jul;72(3):777-82
pubmed: 25663505
Biomed Mater. 2015 Mar 16;10(3):034002
pubmed: 25775166
Brain Res Bull. 2015 Aug;117:1-9
pubmed: 26073842
Biosci Rep. 2015 May 07;35(3):null
pubmed: 26182370
J Cell Physiol. 2016 Sep;231(9):1876-93
pubmed: 26754581
Elife. 2016 Jan 14;5:e09100
pubmed: 26765569
Invest Ophthalmol Vis Sci. 2016 Apr 1;57(4):2344-54
pubmed: 27127934
Ageing Res Rev. 2016 Aug;29:26-41
pubmed: 27242026
Ophthalmic Res. 2017;57(2):77-86
pubmed: 27618367
J Cell Sci. 2017 Jan 1;130(1):203-218
pubmed: 27663511
Drug Discov Today. 2017 Feb;22(2):327-339
pubmed: 27989722
Exp Eye Res. 2017 Feb;155:91-98
pubmed: 28153738
Biomacromolecules. 2017 Mar 13;18(3):709-718
pubmed: 28157290
Invest Ophthalmol Vis Sci. 2017 Dec 1;58(14):6113-6122
pubmed: 29222553
Exp Eye Res. 2018 Jun;171:164-173
pubmed: 29526795
Biomicrofluidics. 2018 May 16;12(4):042204
pubmed: 29861815
Acta Biomater. 2018 Jul 15;75:200-212
pubmed: 29864516
Int J Mol Med. 2019 Feb;43(2):671-681
pubmed: 30483726
J Immunol Methods. 1983 Dec 16;65(1-2):55-63
pubmed: 6606682
Oncogene. 1996 Aug 15;13(4):665-75
pubmed: 8761287
Cancer Res. 1997 Jul 1;57(13):2687-93
pubmed: 9205078

Auteurs

Stefania Vernazza (S)

IRCCS, Fondazione G.B. Bietti, Rome, Italy.

Sara Tirendi (S)

Department of Experimental Medicine (DIMES), University of Genoa, Genoa, Italy.
Inter-University Center for the Promotion of the 3Rs Principles in Teaching & Research (Centro 3R), Italy.

Sonia Scarfì (S)

Inter-University Center for the Promotion of the 3Rs Principles in Teaching & Research (Centro 3R), Italy.
Department of Earth, Environment and Life Sciences (DISTAV), University of Genoa, Genoa, Italy.

Mario Passalacqua (M)

Department of Experimental Medicine (DIMES), University of Genoa, Genoa, Italy.
Inter-University Center for the Promotion of the 3Rs Principles in Teaching & Research (Centro 3R), Italy.

Francesco Oddone (F)

IRCCS, Fondazione G.B. Bietti, Rome, Italy.

Carlo Enrico Traverso (CE)

Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.

Ilaria Rizzato (I)

Inter-University Center for the Promotion of the 3Rs Principles in Teaching & Research (Centro 3R), Italy.
Department of Modern Languages and Cultures (LCM), University of Genoa, Genoa, Italy.

Anna Maria Bassi (AM)

Department of Experimental Medicine (DIMES), University of Genoa, Genoa, Italy.
Inter-University Center for the Promotion of the 3Rs Principles in Teaching & Research (Centro 3R), Italy.

Sergio Claudio Saccà (SC)

IRCCS, San Martino General Hospital, Ophthalmology Unit, Genoa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH